GSK's China sales 'a little better' says Dingemans
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline saw sales in China getting "a little bit better" at the end of the third quarter of 2013, according to finance chief Simon Dingemans who was speaking at the JP Morgan healthcare meeting earlier this week. GSK reported a 61% drop in revenues during the third quarter following an ongoing bribery investigation, something AstraZeneca CEO Pascal Soriot couldn't help commenting on when he spoke at JPM (scripintelligence.com, 15 January 2014).